Safety and Efficacy of Belatacept Conversion Following Kidney Transplant

被引：0
|
作者：
Bixby, A. [1 ]
Hampton, A. [2 ]
Ecabert, D. [1 ]
Burrelli, C. [1 ]
机构：
[1] Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA
[2] Ohio Northern Univ, Ada, OH USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2023年 / 23卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
B212
引用
收藏
页码：S850 / S850
页数：1
相关论文
共 50 条
  • [21] IMPACT OF BELATACEPT CONVERSION ON KIDNEY TRANSPLANT FUNCTION, HISTOLOGY AND GENE EXPRESSION
    Sanghi, P.
    Halloran, P.
    Kumar, D.
    Reeve, J.
    Levy, M.
    Sharma, A.
    Fattah, H.
    Kimball, P.
    Massey, H. D.
    King, A. L.
    Gupta, G.
    NEPHROLOGY, 2017, 22 : 15 - 15
  • [22] Conversion to Belatacept in Kidney Transplant Recipients with Systemic Lupus Erythematosus.
    Carrion Barbera, I.
    Fajardo, M. C.
    Tsapepas, D.
    Gartshteyn, J.
    Askanase, A.
    Fernandez, H. E.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 692 - 693
  • [23] Belatacept for kidney transplant recipients
    Masson, Philip
    Henderson, Lorna
    Chapman, Jeremy R.
    Craig, Jonathan C.
    Webster, Angela C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (11):
  • [24] Cardiovascular Risk Following Conversion to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial
    Bredewold, Obbo W.
    Chan, Joe
    Svensson, My
    Bruchfeld, Annette
    de Fijter, Johan W.
    Furuland, Hans
    Grinyo, Josep M.
    Hartmann, Anders
    Holdaas, Hallvard
    Hellberg, Olof
    Jardine, Alan
    Mjornstedt, Lars
    Skov, Karin
    Smerud, Knut T.
    Soveri, Inga
    Sorensen, Soren S.
    van Zonneveld, Anton-Jan
    Fellstrom, Bengt
    KIDNEY MEDICINE, 2023, 5 (01)
  • [25] Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction
    Kuten, Samantha A.
    Patel, Samir J.
    Baru, Ashvin
    Gaber, A. Osama
    Crutchley, Rustin D.
    Ramanathan, Venkataraman
    Knight, Richard J.
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (05)
  • [26] Belatacept for kidney transplant recipients
    Webster, Angela
    NEPHROLOGY, 2015, 20 (10) : 752 - 754
  • [27] Time-Varying Belatacept Exposure and Its Relationship to Efficacy/Safety Responses in Kidney-Transplant Recipients
    Zhou, Z.
    Shen, J.
    Hong, Y.
    Kaul, S.
    Pfister, M.
    Roy, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (02) : 251 - 257
  • [28] Efficacy of Belatacept Conversion Protocols
    Yazdi, M.
    Kahwaji, J.
    Meguerditchian, S.
    Lee, R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 680 - 681
  • [29] Conversion to Belatacept in Maintenance Kidney Transplant Patients: A Retrospective Multicenter European Study
    Darres, Amandine
    Ulloa, Camillo
    Brakemeier, Susanne
    Garrouste, Cyril
    Bestard, Oriol
    Del Bello, Arnaud
    Soussan, Rebecca Sberro
    Duerr, Michael
    Budde, Klemens
    Legendre, Christophe
    Kamar, Nassim
    TRANSPLANTATION, 2018, 102 (09) : 1545 - 1552
  • [30] Conversion to Belatacept Based Immunosuppression Regimen in Kidney Transplant Patients: Lessons Learned
    Saidi, R.
    Huang, N.
    Yang, C.
    Movileanu, I.
    Ecal, K.
    Senay, A.
    Pankewycz, O.
    Dvorai, R.
    Shahbazov, R.
    Laftavi, M.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 432 - 432
12345